Safety and Tolerability of Carboxyamidotriazole Orotate (CTO) in Solid Tumors or With Temodar® in Glioblastoma or Other Recurrent Malignant Gliomas or in Combination With Temodar® and Radiation Therapy for Patients With Newly Diagnosed Glioblastoma and Malignant Gliomas
Phase 1 Unknown
100 enrolled
OUTREACH
Phase 1 Unknown
75 enrolled
A Study of IMU-201 (PD1-Vaxx), a B-Cell Immunotherapy, in Adults with Non-Small Cell Lung Cancer
Phase 1 Unknown
24 enrolled
Clinical Trial of HG146 Administered to Subjects with Advanced Solid Tumors or Lymphoma
Phase 1 Unknown
96 enrolled
A Clinical Study to Evaluate the Safety, Tolerability and Efficacy of IOS-1002 Administered Alone and in Combination with Pembrolizumab, a PD-1 Monoclonal Antibody in Advanced Solid Tumors
Phase 1 Unknown
140 enrolled
Determine Function of Antroquinonol in Combination With SOC in First Line Metastatic Pancreatic Cancer
Phase 1/2 Unknown
52 enrolled
A Study of Bi-Ligand-Drug Conjugate CBP-1019 in Patients With Advanced Solid Tumors
Phase 1/2 Unknown
260 enrolled
The Efficacy of the IUrisure for Detection of Recurrent Urothelial Carcinoma
Unknown
148 enrolled
Effect of NUTRICAN to Improve Nutritional Status in Cancer Patients
Phase 3 Unknown
108 enrolled
A Phase 1 Study of BST02 in Treating Locally Advanced Liver Cancer
Phase 1 Unknown
9 enrolled
AMT-562 in Patients With Selected Advanced Solid Tumors
Phase 1 Unknown
72 enrolled
ELITE
Unknown
1,200 enrolled
Phase I Study of Cell Therapies for the Treatment of Patients With Relapsed or Refractory AML or High-risk MDS
Phase 1 Unknown
24 enrolled
A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
Phase 1 Unknown
77 enrolled
CLiMB
Unknown
1,900 enrolled
U87 CART in Treatment of Advanced Solid Tumor
Phase 1 Unknown
12 enrolled
A Phase Ib/â…¡ Study of NTQ1062 in Combination With Fulvestrant in Patients With Advanced HR Positive /HER-2 Negative Breast Cancer
Phase 1 Unknown
42 enrolled
A Phase I Study to Investigate the Safety, Tolerability and PK of HLX60 (Anti-GARP Monoclonal Antibody) in Subjects With Solid Tumors or Lymphoma
Phase 1 Unknown
11 enrolled
A Phase Ib/II Clinical Study of HRS-1167 in Combination With Bevacizumab in Patients With Recurrent Ovarian Cancer
Phase 1/2 Unknown
54 enrolled
A Project to Test the Efficacy and Safety of An Innovative Treatment for Opiate Use Disorders.
Phase NA Unknown
130 enrolled
The Effect Of Fractional CO2 Laser Therapy On Cancer Survivors With Genitourinary Syndrome Of Menopause (GSM)
Phase NA Unknown
68 enrolled
A Clinical Trial of TQB2934 for Injection in Multiple Myeloma Subjects
Phase 1 Unknown
140 enrolled
A Clinical Study of MIL93 in Solid Tumors.
Phase 1 Unknown
228 enrolled
Stool Sample Collection Study
Unknown
40 enrolled
Safety/Tolerability, PK and Efficacy of IMB071703 Injection in Patients With Advanced Solid Tumors
Phase 1 Unknown
93 enrolled
NOVA-II
Phase 2 Unknown
170 enrolled
Intravenous T3011 Given as a Single Agent and in Combination With Other Therapy in Subjects With Advanced Solid Tumors
Phase 1/2 Unknown
42 enrolled
A Phase I Study to Assess PSMA+ and PSMA- Tumour Lesions
Phase 1 Unknown
5 enrolled
An Efficacy and Safety Study of ICP-192 in Subjects With Bladder Urothelial Cancer
Phase 2 Unknown
115 enrolled
JALOSOME-01
Phase NA Unknown
57 enrolled
Evaluate CART-BCMA in Patients With Relapsed and/or Refractory Multiple Myeloma
Phase 1 Unknown
15 enrolled
The Safety and Efficacy of SNC-109 CAR-T Cells Therapy the Recurrent Glioblastoma
Phase 1 Unknown
16 enrolled
Phase I Study to Evaluate Safety and Anti-tumor Activity of PB101, an Anti-angiogenic Immunomodulating Agent
Phase 1 Unknown
30 enrolled
F01 in the Treatment of Relapsed/Refractory Non-hodgkin's Lymphoma
Phase 1 Unknown
55 enrolled
GT90001 Plus Nivolumab in Patients With Advanced Hepatocellular Carcinoma
Phase 2 Unknown
5 enrolled
ECOBASO
Phase NA Unknown
704 enrolled
Utility and Usability of ActivSightâ„¢ Laser Speckle Imaging in Visualization of Tissue Perfusion and Blood Flow During Esophageal Surgery in Humans
Phase NA Unknown
70 enrolled
A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of SKI-G-801 in Patients With Advanced Solid Tumors
Phase 1 Unknown
36 enrolled
A Study of RC48-ADC Administered Intravenously to Patients With HER2-Positive Metastatic Breast Cancer With or Without Liver Metastases
Phase 2/3 Unknown
301 enrolled
A Study Comparing the Efficacy and Safety of G-CHOP Versus R-CHOP in Untreated Diffuse Large B-cell Lymphoma Patients
Phase 3 Unknown
360 enrolled
Clinical Study of IAH0968 in Patients With HER2-positive Advanced Solid Tumors
Phase 1/2 Unknown
97 enrolled
A Study of RC48-ADC in Advanced Melanoma Subjects With HER2 Variant (Mutation, Amplification, Overexpression)
Phase 2 Unknown
50 enrolled
A Study of RC48-ADC Combined With JS001 For Perioperative Treatment of Muscle-Invasive Bladder Cancer
Phase 2 Unknown
40 enrolled
To Evaluate IAH0968 in Combination With CAPEOX in HER2-positive Metastatic Colorectal Cancer
Phase 2/3 Unknown
279 enrolled
IAH0968 in Combination With GC for the Treatment of HER2-Positive Unresectable Advanced/Metastatic Malignant Tumors
Phase 1/2 Unknown
136 enrolled
Non-invasive Biomarker Discovery for Pre-cervical or/and Cervical Cancer-HPV DNA and Other Biomarkers in Urine
Phase NA Unknown
300 enrolled
RVU120 in Patients With Acute Myeloid Leukemia or High-risk Myelodysplastic Syndrome
Phase 1 Unknown
112 enrolled
PBF-1129 in Patients With NSCLC
Phase 1 Unknown
18 enrolled
A Phase Ib/II Study of GT90001 Combined With KN046 in Solid Tumors
Phase 1/2 Unknown
216 enrolled
Mitoxantrone Hydrochloride Liposome Injection in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL)
Phase 2 Unknown
104 enrolled